Targeting the SARS-CoV-2 3CLpro  and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors

Future Cardiology, Ahead of Print.

Source: Future Cardiology - February 12, 2021 Category: Cardiology Authors: Milad Shirvaliloo Source Type: research